TABLE 1.
miRNA | Model | Signaling pathways/Target | Result | References |
---|---|---|---|---|
miR-20a | Human aortic endothelial cells (HAECS) | TLR、TXNIP | Negatively regulates TLR4 and NLRP3 signaling to protect HAECs from inflammatory injuries, inhibits the atherosclerotic development | Chen et al. (2018) |
miR-30c-5p | HAECs | FOXO3 | Inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis, anti-atherosclerosis | Li et al. (2018) |
miR-125a-5p | Human umbilical vein endothelial cells | TET2 | Activates NLRP3 inflammasome and caspase-1, promotes pyroptosis and atherosclerosis progression | Zhaolin et al. (2019b) |
Human vascular smooth muscle cells | CCL4 | Inhibits expression of NLRP3、ASC、caspase-1 and IL-1β proteins, anti-atherosclerosis | Jiawang Wang et al. (2019) | |
miR-223 | Primary macrophages | NLRP3 | Inhibits NLRP3 inflammasome | Bauernfeind et al. (2012) |
miR-9 | Human THP-1 derived macrophages | JAK1/STAT1 | Inhibits activation of the NLRP3 inflammasome, attenuates atherosclerosis-related inflammation | Wang et al. (2017) |
miR-181a | THP‐1 macrophages | MEK1 | Inhibits the expression of NLRP3 inflammasome-related proteins, alleviates pyroptosis | Song et al. (2019) |
miR-33 | Bone marrow derived macrophages, Ldlr −/− mice | Prkaa1 | Promotes pyroptosis and atherosclerosis progression | Tumurkhuu et al. (2016) |
miR-155 | THP-1 macrophages, ApoE−/- mice | ERK1/2 | Increases the expression of NLRP3 inflammasome and the secretion of IL-1β and IL-18, aggravates the carotid atherosclerosis lesion | Yin et al. (2019) |
miR-145 | Vascular smooth muscle cells, ApoE−/- mice | CD137/NFATc1 | Inhibits NLRP3 inflammasome and pyroptosis, increases the stability of atherosclerosis lesions | Zhong et al. (2018) |
TLR, toll-like receptors; TXNIP, thioredoxin-interacting protein; FOXO3, Forkhead box O3; TET, ten-eleven translocation; CCL4, C-C motif chemokine 4-like; JAK1, Janus kinase 1; MEK1, MAP, kinase 1; Prkaa1, AMP, kinase; NFATc1, nuclear factor of activated T cells1.